Wanbury P/E Ratio
Wanbury P/E ratio. Wanbury (WANBURY) P/E ratio is 16.18 (Moderate), EPS (TTM) ₹9.32, current price ₹190.46 on NSE vs historical average P/E of 8.17 (100.0th percentile) — Moderate - Fairly valued. Also explore Wanbury share price performance to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
WANBURY P/E Ratio — Valuation Signal & Historical Context
Wanbury P/E 16.18 vs historical average 8.17, range 6.78–9.56 — signal: Fairly Valued. Examine Wanbury quarterly financials for recent quarterly revenue, profit and EPS trends.
- Current PE is 98.0% above historical average
- Trading at discount to sector average PE of 56.4
Wanbury P/E Ratio Historical Trend
WANBURY annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 16.18 vs historical average 8.17. For live price, revenue and the complete fundamental profile, see Wanbury share price today.
WANBURY Historical P/E Ratio — EPS, Year-End Price & Valuation
Wanbury annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 9.56 | 13.42 | ₹128.30 | NSE | Low |
| 2023 | 6.78 | 7.13 | ₹48.35 | NSE | Low |
WANBURY vs Healthcare Peers — P/E Ratio Comparison
Wanbury P/E 16.18 vs Healthcare average 56.4, median 32.5 — range 2.04–740.29.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |